Glass Bubble Polymer Matrix for Low-Noise Analyte Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing heterogeneous assays face challenges such as magnet proximity issues, interference from ferromagnetic substances, particle aggregation, quenching of luminescence, and sample complexity, leading to reduced sensitivity and accuracy, especially in detecting low-concentration analytes like mycotoxins and other compounds.

Innovation Solution

A composition comprising a polymer matrix with hollow glass bubbles covalently attached to affinity groups, allowing analytes to float to the surface for detection, eliminating the need for mechanical separation and enabling multiplexing by sequential binding of target analytes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If magnetic beads are used for analyte detection, then detection sensitivity is improved, but non-specific binding increases causing false positives

Engineering Contradiction:
Improvedetection sensitivityVSAvoidnon-specific binding
Core Design Contradiction:
Measurement precisionVSObject-generated harmful factors

Solution Approach 1:

The patent applies local quality by creating heterogeneous antibody populations on magnetic bead surfaces with different orientations and affinities. Specifically, antibodies are positioned in two distinct populations: those oriented toward the magnetic bead core for high-affinity binding, and those oriented away from the core for analyte interaction. This spatial differentiation of antibody properties enables specific analyte detection while minimizing non-specific binding to the bead surface.

Inventive Principle:
Principle #3Local quality

2Measurement precision

If more antibodies are added to increase detection signal, then detection sensitivity improves, but background noise from non-specific binding increases

Engineering Contradiction:
Improvedetection signalVSAvoidbackground noise
Core Design Contradiction:
Measurement precisionVSObject-generated harmful factors

Solution Approach 1:

The patent segments the antibody population into two distinct functional groups based on their orientation relative to the magnetic bead core. One population of antibodies is oriented toward the core and does not bind analyte, serving as inert mass that generates magnetic signal without contributing to non-specific binding. The second population is oriented away from the core and binds analyte specifically. This segmentation allows the system to increase total antibody quantity for enhanced signal while the oriented population maintains low non-specific binding background.

Inventive Principle:
Principle #1Segmentation

3Device complexity

If conventional magnetic bead assays are used, then device complexity is low, but detection precision deteriorates due to non-specific binding

Engineering Contradiction:
Improveassay simplicityVSAvoiddetection precision
Core Design Contradiction:
Device complexityVSMeasurement precision

Solution Approach 1:

The patent applies preliminary action by pre-orienting antibodies in two distinct populations during the bead preparation process before the actual detection assay. This pre-orientation is achieved through controlled conjugation methods that create antibodies facing the bead core and antibodies facing outward. By establishing this oriented structure in advance, the assay maintains simplicity in execution while achieving high detection precision through reduced non-specific binding during the detection process.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method provides high sensitivity and accuracy in detecting multiple analytes simultaneously, reducing interference and aggregation, and allowing for efficient separation without mechanical forces, particularly effective for low-concentration analytes like mycotoxins.

Implementation Method 1

Compositions and methods of detecting analytes utilizing magnetic beads conjugated with oriented antibodies

Methodology Applied
Scientific EffectAntibody-antigen binding:

Data Source

PatentEP4308930B1Compositions and methods of detecting analytes
Publication Date: 2026.05.20 NEOGEN FOOD SAFETY US HOLDCO CORP
  • EP4308930B1 patent drawingFigure 1~2
  • EP4308930B1 patent drawingFigure 3~4
  • EP4308930B1 patent drawingFigure 5A~5B

AI summary

Compositions comprising a polymer matrix or film having dispersed therein a plurality of glass bubbles with affinity groups bound thereto, and methods of detecting target analytes using the same.